# Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer

> **NCT06097416** · PHASE3 · NOT_YET_RECRUITING · sponsor: **St. James's Hospital, Ireland** · enrollment: 100 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Neoadjuvant Chemoradiotherapy
- **DRUG:** Total Neoadjuvant Therapy

## Key facts

- **NCT ID:** NCT06097416
- **Lead sponsor:** St. James's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10
- **Primary completion:** 2025-10
- **Final completion:** 2030-10
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097416, "Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06097416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*